| Bookmarkers beware: Bookmarks to pages other than the home page may not work after we change our server in April |
|
BMJ No 7129 Volume 316 7 February 1998 This Week in BMJ | Editor's Choice | Press releases Receive this page by email each week
Editorials 403
Do silicone breast implants cause connective tissue disease?
404
Neonatal screening for cystic fibrosis
405
Missed problems and missed opportunities for addicted doctors
406
Turbulent future for school nursing and health visiting
407
Caring for patients with chronic leg ulcer
409
Providing primary care in the accident and emergency department
410
Rationing health care
News 411
Consultation on human cloning launched in UK
Papers 417
Risk of connective tissue disease and related disorders among women
with breast implants: a nationwide retrospective cohort study in
Sweden 422
Single dose vitamin A treatment in acute shigellosis in Bangladeshi
children: randomised double blind controlled trial
426
Mortality from overdose among injecting drug users recently released
from prison: database linkage study 429
Evaluation of adjuvant psychological therapy in patients with
testicular cancer: randomised controlled trial
435
Evaluation of reagent strips in detecting asymptomatic bacteriuria in
early pregnancy: prospective case series
437
Is the emergency (999) service being misused? Retrospective
analysis 438
Raynaud's phenomenon after sympathetic denervation in patients with
primary autonomic failure: questionnaire survey
440
Drug points: Serious interaction between warfarin and oral terbinafine
Parotid swelling and terbinafine
Nortriptyline intoxication induced by terbinafine
435
Corrections: Randomised controlled trial to evaluate early discharge
scheme for patients with stroke 441
Intranasal chlorhexidine resulting in anaphylactic circulatory
arrest
General practice 442
Qualitative study of educational interaction between general
practitioners and specialists
Clinical review 446
Science, medicine, and the future: Alzheimer's
disease 449
Grand Round: Mycobacterium paratuberculosiscervical
lymphadenitis, followed five years later by terminal ileitis similar to
Crohn's disease
454
Lesson of the week: Pneumatic compression boots for prophylaxis against
deep vein thrombosis: beware occult arterial disease
456
ABC of palliative care: Bereavement
Education and debate
Who wants the procedure and why
Commentary: The ethical issue is deceit
Commentary: Promiscuity is acceptable only for
men
Commentary: Education about the hymen is
needed
Commentary: Cultural complexities should not be
ignored
Commentary: Surgery is not what it seems
463
Lay perspectives: advantages for health
research 466
Continuing medical education: Learning and change: implications
for continuing medical education
Letters 469
Bias in meta-analysis detected by a simple, graphical
test 471
British renal registry is fully electronic
472
Electronic record linkage to create diabetes
registers 473
Under half of senior house officers in Anglia in 1997 were United
Kingdom graduates 473
UK encourages unrealistic expectations among overseas applicants for
training 473
Adding methionine to every paracetamol tablet
474
British trial of transmyocardial revascularisation is
continuing 475
Comparison of assays for measuring plasma paracetamo 476
Prescription Medicines Code of Practice Authority investigates
criticisms of advertisements
476
Psychotropic drug treatment
477
Media are too eager to link silicone to disease
Obituaries 478 M Critchley, J M England, E C Gambrill, G St J Hallett, J M Hand, W Howel-Evans, J C Lindsay, R Lynn, A F McGlashan, J D Milne, A H W Nias, G H Pearce
Medicopolitical digest 480
Doctors who misuse alcohol
Views & reviews Soundings 482
None of our business?
Personal views 482 Living in two worlds
A psychiatrist in the family
Medicine and the media 484
To screen or not to screen?
Medicine and books 485
Who's Afraid of Human Cloning? Gregory E
Pence
Western Medicine: An Illustrated History Ed
Irvine Loudon
Minerva 486
S2 Career Focus Classified supplement When your partner is your partner
Editor's choiceWhat is happening with Alzheimer's disease?All readers of the BMJare likely to be interested in what will happen with the management of Alzheimer's disease. A fifth of us may well develop it. Colin Masters and Konrad Beyreuther consider the disease in one of our continuing series entitled "Science, Medicine, and the Future" (p 446). The idea behind these articles is to describe what is happening now with the science of the disease and to speculate on what that may mean for clinicians in the future. "An avalanche of knowledge" has confirmed that the generation of Aß amyloid from the amyloid precursor protein is the central pathway in the disease. How the Aß amyloid exerts its toxicity is unclear, but about half the genes that cause Alzheimer's disease have now been identified. The important environmental factors remain undiscovered. Low education, head trauma, smoking, concomitant vascular disease, diabetes, and the menopause all have effects - but they are modest and inconsequential. Might some subtle factor in the Western diet or lifestyle prove to be a major factor? Masters and Beyreuther speculate that by 2008 we might see screening for the genes linked with the disease and possible presymptomatic treatment. There might also be drugs that will act on the amyloidogenic pathway and modify the course of the disease. Currently three drugs are on the market for treating Alzheimer's disease, four await approval, and 16 undergoing early clinical evaluation. Most act on the cholinergic system and are likely to have only a small effect, but drugs that target the amyloidogenic pathway are emerging. Despite the high prevalence, immense cost, and exciting science of Alzheimer's disease many more column inches have probably been devoted by the media to the issue of whether silicone breast implants may cause connective tissue disease (p 403). No good epidemiological evidence has ever suggested that they do, and we publish today a Swedish study comparing connective tissue disease in 7,442 women with implants and 3,353 women who underwent breast reduction (p 417). There was no difference between the groups. Yet on the basis of weak anecdotal evidence American manufacturers have paid out over $4 billion to women with breast implants and the British government has set up an inquiry into the subject. A legal sideline is the probably baseless argument that women with silicone implants may damage their babies through breastfeeding (p 477). Finally, a Paris newspaper attracted the attention of the BMJ100 years ago by proposing to "keep a doctor" in the way a London tailor kept a poet (p 448). The journal was snooty, and a century later we are still suspicious of doctors who peddle their wares in the newspapers (p 484).
Home | Current contents | Past issues | Classified ads | Career Focus | Feedback Collections | About this site | About the BMJ | BMA | Medline
|